Home/Filings/4/0001062993-22-004465
4//SEC Filing

Thomas James D 4

Accession 0001062993-22-004465

CIK 0001021561other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:43 PM ET

Size

8.1 KB

Accession

0001062993-22-004465

Insider Transaction Report

Form 4
Period: 2022-02-11
Thomas James D
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-11+2,7102,710 total
    Exercise: $48.81From: 2022-02-15Exp: 2028-02-15Class A Common Stock (2,710 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-11+9,0029,002 total
    Exercise: $30.45From: 2022-02-11Exp: 2027-02-15Class A Common Stock (9,002 underlying)
Footnotes (2)
  • [F1]On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.
  • [F2]On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Issuer

NU SKIN ENTERPRISES, INC.

CIK 0001021561

Entity typeother

Related Parties

1
  • filerCIK 0001784360

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:43 PM ET
Size
8.1 KB